HCQ has a novel mechanism of action of post-receptor inhibition of insulin degradation for reducing blood glucose levels. Various studies have shown that the use of HCQ reduces the incidence of T2DM. In this exclusive KOL Interview, Dr. Sushil Jindal explains, ‘ The mechanism of action and the recovery of hydroxychloroquine as compared to other drugs .’ Dr.
Sushil Jindal is currently working as Professor of Medicine with PCMS in Bhopal. He has sixteen international publications to his credit in addition to two chapters which he has contributed in RSSDI Textbook of Diabetes. He is a member of an editorial board of prestigious journal 'BMJ Case Reports' and chief editor of Hindi diabetes education magazine "Madhumeh Vani' and its website. He is a physician to the Governor of Madhya Pradesh.
